2067 The Real Use of Beta-Lactams After "Penicillin Allergic" Label Removal

Monday, 5 December 2011
Poster Hall (Cancún Center)

Shai Cohen, MD , Allergy Clinic Lin Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology , Haifa, Israel

Areen Khateeb-Alabbasi, MHA , Allergy Clinic Lin Medical Center, School of Public Health, University of Haifa, Haifa , Israel

David Nusem, MD , Allergy Clinic Lin Medical Center, Haifa, Israel

Josef Panassof, MD , Allergy Clinic Lin Medical Center, Haifa, Israel

Background: The "penicillin allergic" label becomes very common, thus preventing from many patients the use of one of the most efficient antibiotic drugs, with the lowest cost and toxic effects. However, approximately 80% of patients with a history of penicillin allergy have negative results if they are skin tested and can actually use this drug class. We sought to determine whether in real life, removal of the label is implemented to the treatment of beta-lactams when it is required.  

Methods: A retrospective study that includes all penicillin allergy history–positive/penicillin skin test–negative/oral amoxicillin challenge-non reactive individuals who had been tested in advance of need between the years 2000-2009 at one medical center (n=140). To uncover late reactions, they were offered after the test a five day course of amoxicillin. The study tool was a phone-questionnaire assessing the patients' confidence in their test results, and whether they have used penicillin since testing.

Results: 106 patients (76%) agreed to participate in the survey. Ninety nine patients (93%) chose to take the five day course of amoxicillin. From this group of patients twenty seven (27.2%) answered that they feel intermediate insecurity and fourteen (14.1%) that they feel complete insecurity to receive penicillin. Since having the test seventy two (72.7%) of the 99 needed penicillin. Sixty two (86.1%) indeed took a beta-lactam while 10 patients (13.9%) chose to receive another antibiotic class due to their or their physician's disbelief in the test. All the patients (n=7) who chose not to take the course of amoxicillin after the test stated that they feel complete insecurity to receive penicillin. Four (57.1%) of these patients had a disease that requires a beta-lactam antibiotic and actually, none of them agreed to take one (P=0.01).

Conclusions: A negative penicillin test done in advance of need even when includes an oral challenge may not be enough to convince patients that they can use beta-lactams. Our study suggests that giving a five day course of amoxicillin after the test increases the patients' confidence in the results.